---
title: "Istradefylline - Parkinson'S Disease"
sidebar: mydoc_sidebar
permalink: db11757-mesh-d010300-1.html
toc: false 
---


Path ID: `DB11757_MESH_D010300_1`
{% include image.html url="images/db11757-mesh-d010300-1.png" file="db11757-mesh-d010300-1.png" alt="db11757-mesh-d010300-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C111599 | Istradefylline | Drug |
| UniProt:P29274 | Adenosine receptor A2a | Protein |
| MESH:D000241 | Adenosine | ChemicalSubstance |
| UniProt:P14416 | D(2) dopamine receptor | Protein |
| MESH:D004298 | Dopamine | ChemicalSubstance |
| GO:0001963 | Synaptic transmission, dopaminergic | BiologicalProcess |
| MESH:D010300 | Parkinson's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Istradefylline | DECREASES ACTIVITY OF | Adenosine Receptor A2A |
| Adenosine Receptor A2A | MOLECULARLY INTERACTS WITH | Adenosine |
| Adenosine | DECREASES ACTIVITY OF | D(2) Dopamine Receptor |
| D(2) Dopamine Receptor | MOLECULARLY INTERACTS WITH | Dopamine |
| Dopamine | POSITIVELY CORRELATED WITH | Synaptic Transmission, Dopaminergic |
| Synaptic Transmission, Dopaminergic | NEGATIVELY CORRELATED WITH | Parkinson'S Disease |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB11757#BE0000924](https://go.drugbank.com/drugs/DB11757#BE0000924)
  - [https://en.wikipedia.org/wiki/Istradefylline](https://en.wikipedia.org/wiki/Istradefylline)
